#VisualAbstract: Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer
1. Enzalutamide along with androgen-deprivation therapy was shown to significantly increase median overall survival among men with non-metastatic, castration-resistant prostate ...